Skip to main content

Lactose Intolerance

0
Pipeline Programs
4
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Purdue Pharma
Purdue PharmaCT - Stamford
3 programs
Bifidobacterium adolescentis IVS-1 capsuleN/A1 trial
Milk containing A1 and A2 beta-caseinN/A1 trial
Milk containing A1 and A2 beta-caseinN/A1 trial
Active Trials
NCT05668468Unknown35Est. May 2024
NCT05669274Unknown35Est. Dec 2025
NCT05660278Unknown35Est. Aug 2025
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Lactose solution/Glucose solutionN/A1 trial
Active Trials
NCT06177938Recruiting120Est. Dec 2025
Advanced Solutions Life Sciences
1 program
Lactose-Containing MilkN/A
Azenta Life Sciences
1 program
Lactose-Containing MilkN/A1 trial
Active Trials
NCT06513026Recruiting40Est. Apr 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Azenta Life SciencesLactose-Containing Milk
Allergy TherapeuticsLactose solution/Glucose solution
Purdue PharmaBifidobacterium adolescentis IVS-1 capsule
Purdue PharmaMilk containing A1 and A2 beta-casein
Purdue PharmaMilk containing A1 and A2 beta-casein

Clinical Trials (5)

Total enrollment: 265 patients across 5 trials

NCT06513026Azenta Life SciencesLactose-Containing Milk

Milk for Diabetes Prevention

Start: Apr 2026Est. completion: Apr 202840 patients
N/ARecruiting
NCT06177938Allergy TherapeuticsLactose solution/Glucose solution

Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers

Start: Jun 2024Est. completion: Dec 2025120 patients
N/ARecruiting
NCT05668468Purdue PharmaBifidobacterium adolescentis IVS-1 capsule

A Bifido Bacteria to Improve Lactose Digestion and Tolerance

Start: May 2022Est. completion: May 202435 patients
N/AUnknown
NCT05660278Purdue PharmaMilk containing A1 and A2 beta-casein

Comparing the Inflammation, Maldigestion and Symptoms Due to Commercial Milk and A2 Milk

Start: Jan 2022Est. completion: Aug 202535 patients
N/AUnknown
NCT05669274Purdue PharmaMilk containing A1 and A2 beta-casein

Comparing the Adaptation of Commercial Milk and A2 Milk in Lactose Maldigesters

Start: Dec 2021Est. completion: Dec 202535 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 265 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.